Recently, the 2024 edition of the "China Drug Administration Yearbook," compiled and published by the National Medical Products Administration, was officially released. Tianjiquan Group, with its excellent corporate image, high-quality medical products, and superior services, was successfully selected for inclusion in the yearbook, becoming an industry benchmark enterprise that has attracted much attention. This honor not only highlights the group's outstanding achievements and solid market position in the field of innovative research and development, but also signifies the high recognition of Tianjiquan Group's product strength and brand value by the national drug supervision and administration department.

"China Drug Administration Yearbook" (2024)

As a product highlighted in the "China Drug Administration Yearbook" (2024), the Tianjiquan G SLT conductor laser therapeutic device is non-invasive and infection-free; it is compact and lightweight, easy to operate, and not limited by time or location; it performs laser irradiation on the nasal cavity or acupoints, serving as an adjuvant therapy for vascular headaches, cerebral infarction, cerebral trauma sequelae, and chronic cardiovascular and cerebrovascular diseases.

"China Drug Administration Yearbook" (2024)

Since its first volume was published in 1999, the "China Drug Administration Yearbook" has become an authoritative tool for comprehensively recording the history, progress, and achievements of the safety supervision of food, drugs, medical devices, health foods, and cosmetics in China. Its core characteristics are "accuracy, authority, practicality, and continuity". The distribution covers regulatory agencies at all levels, relevant production and operation enterprises, inspection units, research institutes, medical institutions, and various libraries, making it an important reference for industry development.

"China Drug Administration Yearbook (2024) Tianjiquan Page Details"

Founded in 2001, Tianjiquan Group is a national high-tech enterprise that has been deeply involved in the health industry for 25 years, always adhering to the concept of "Innovation First, Customer First, Quality First, Service First". Under the leadership of Chairman and President Shi Yanbao, the company focuses on cutting-edge technology research, attaches great importance to technological innovation and product development, and has completed the research and development of multiple new products and patents. Over the past 25 years, Tianjiquan Group has continuously integrated advantageous resources, cultivated and introduced a group of excellent scientific researchers, and adhered to technological innovation. With products such as the QRS Quantum Resonance Health Information Detector and the GSLT Semiconductor Laser Therapeutic Apparatus, Tianjiquan Group has become a leader in the green health field and also a preferred brand for consumer healthcare.

The leaders of the board of directors of Tianji Quan Group attach great importance to product innovation and research and development

Over the past 25 years since its establishment, Tianjiquan Group has consistently adhered to its original corporate mission of "Boundless love, spreading health; One goal, curing diseases and saving lives". By keeping its feet on the ground and adapting to market changes, the group has accumulated rich experience and solid strength. Being listed in the national yearbook is not only a recognition of Tianjiquan Group's 25 years of deep industry exploration but also a spur for the group's future development. In the future, Tianjiquan Group will take this opportunity to continue strengthening technological breakthroughs, enhancing scientific research and innovation capabilities, developing more high-quality health products, and contributing to the rise of national brands, thereby making a greater contribution to the cause of public health.